
### [NCIT:C7224](http://purl.obolibrary.org/obo/NCIT_C7224)
**Label:** Plasmablastic Lymphoma

**Subclasses:** [NCIT:C38159](http://purl.obolibrary.org/obo/NCIT_C38159) (Plasmablastic Lymphoma of Mucosa Site), [NCIT:C45216](http://purl.obolibrary.org/obo/NCIT_C45216) (Primary Cutaneous Plasmablastic Lymphoma), [NCIT:C80290](http://purl.obolibrary.org/obo/NCIT_C80290) (Plasmablastic Lymphoma of the Oral Mucosa), 

**Class expressions from DL-Learner:**

- [UBERON:0000167](http://purl.obolibrary.org/obo/UBERON_0000167) (oral cavity) 62.50%
- [NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast) 62.50%
- Thing 52.03%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38650](http://purl.obolibrary.org/obo/NCIT_C38650) (Defective Mu Heavy Chain Present))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38649](http://purl.obolibrary.org/obo/NCIT_C38649) (Vacuolated Plasma Cells in the Bone Marrow))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38648](http://purl.obolibrary.org/obo/NCIT_C38648) (Negative Bone Marrow and Peripheral Blood))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38647](http://purl.obolibrary.org/obo/NCIT_C38647) (Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38646](http://purl.obolibrary.org/obo/NCIT_C38646) (Fried-Egg Appearance of the Bone Marrow))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38645](http://purl.obolibrary.org/obo/NCIT_C38645) (Tartrate Resistant Acid Phosphatase Positive Cells Present))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38644](http://purl.obolibrary.org/obo/NCIT_C38644) (Bone Pain))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38643](http://purl.obolibrary.org/obo/NCIT_C38643) (Extensive Bone Marrow and Blood Involvement))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38642](http://purl.obolibrary.org/obo/NCIT_C38642) (Lymphoblasts 25 Percent or Less of Bone Marrow Nucleated Cells))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38635](http://purl.obolibrary.org/obo/NCIT_C38635) (inv(22q12)))) 47.86%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38536](http://purl.obolibrary.org/obo/NCIT_C38536) (CREB1 Gene))) 47.86%


